About James Peterka

James Peterka is a shareholder in Buchanan’s Chicago office, with a keen focus on Hatch-Waxman, Biologics Price Competition and Innovation Act, and other pharmaceutical and life sciences patent disputes. He has a proven track record defending and advancing the interests of leading biotech companies. From early-stage patent counselling to high-stakes trials and appellate victories, Jim’s expertise includes patent design-around, non-infringement and invalidity strategies, and FDA regulatory challenges. His diverse IP experience also includes food science, materials science and mechanical engineering. As a notable ANDA litigator, James’s innovative client and litigation approach position him as a key driver of IP litigation trends in 2026.